Iodoxamate Meglumine
Generic Name: iodoxamate meglumine
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODOXAMATE MEGLUMINE (40.3%). Application: NDA018076.
Overview
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODOXAMATE MEGLUMINE (40.3%). Application: NDA018076.
Dosage
Available as injectable for injection use.
Related Medications
Amphotericin B Liposome
amphotericin b liposome
Lipid-based Polyene Antifungal [EPC]
DESCRIPTION Amphotericin B liposome for injection is a sterile, non-pyrogenic, yellow lyophilized product for intravenous infusion. Each vial contains amphotericin B, USP, 50 milligrams (mg), intercalated into a liposomal membrane consisting of alpha tocopherol, USP approximately 0.64 mg; cholesterol, NF, 52 mg; distearoyl phosphatidylglycerol sodium salt 86.48 mg; hydrogenated soy phosphatidylcholine 213 mg, together with disodium succinate hexahydrate, NF, 27 mg; and sucrose, NF, 900 mg.
Nalmefene Hydrochloride Injection
nalmefene hydrochloride injection
Nalmefene Hydrochloride Injection Rx only DESCRIPTION Nalmefene Hydrochloride Injection, an opioid antagonist, is a 6-methylene analogue of naltrexone. The chemical structure is shown below: Molecular Formula: C 21 H 25 NO 3 •HCl•H 2 O Molecular Weight: 393.91, CAS # 1228646-72-7 Chemical Name: 17-(Cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol, hydrochloride salt, monohydrate Nalmefene hydrochloride is a white to almost white crystalline powder which is freely soluble in water up.
Menopause Drops
menopause drops
Estrogen [EPC]
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.